Paper16734736
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.
Shimada H and 13 others. Cancer Sci, 2006. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Papers, record 16734736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16734736
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Esophageal Neoplasms | Major topic |
| Genes, p53 | Major topic |
| Genetic Therapy | Major topic |
| Adenoviridae | |
| Aged | |
| Aged, 80 and over | |
| Antibodies, Viral | |
| Drug Resistance, Neoplasm | |
| Female | |
| Genetic Vectors | |
| Humans | |
| Male | |
| Middle Aged | |
| RNA, Messenger | |
| Radiation Tolerance | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Transgenes |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12572873 | p53 gene therapy for esophageal cancer. | J Gastroenterol | 2002 | https://conductscience.org/library/papers/12572873 | PubMed |
| 2 | 16336610 | Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis. | Dis Esophagus | 2005 | https://conductscience.org/library/papers/16336610 | PubMed |
| 3 | 12805322 | Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12805322 | PubMed |
| 4 | 15297186 | A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. | Gynecol Oncol | 2004 | https://conductscience.org/library/papers/15297186 | PubMed |
| 5 | 16142339 | Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells. | Oncol Rep | 2005 | https://conductscience.org/library/papers/16142339 | PubMed |
| 6 | 11870536 | Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma. | Br J Cancer | 2002 | https://conductscience.org/library/papers/11870536 | PubMed |
| 7 | 10414702 | The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability. | Am J Surg | 1999 | https://conductscience.org/library/papers/10414702 | PubMed |
| 8 | 8081915 | Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy. | Endosc Surg Allied Technol | 1994 | https://conductscience.org/library/papers/8081915 | PubMed |
| 9 | 12538456 | Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/12538456 | PubMed |
| 10 | 2263646 | Frequent mutation of the p53 gene in human esophageal cancer. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2263646 | PubMed |
| 11 | 12563234 | Treatment response and prognosis of patients after recurrence of esophageal cancer. | Surgery | 2003 | https://conductscience.org/library/papers/12563234 | PubMed |
| 12 | 9626224 | Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. | J Clin Oncol | 1998 | https://conductscience.org/library/papers/9626224 | PubMed |
| 13 | 11023193 | P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients. | Cancer Gene Ther | 2000 | https://conductscience.org/library/papers/11023193 | PubMed |
| 14 | 11495154 | Preclinical study of adenoviral p53 gene therapy for esophageal cancer. | Surg Today | 2001 | https://conductscience.org/library/papers/11495154 | PubMed |
| 15 | 8782455 | Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. | Nat Med | 1996 | https://conductscience.org/library/papers/8782455 | PubMed |
| 16 | 7621238 | High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. | Cancer Gene Ther | 1994 | https://conductscience.org/library/papers/7621238 | PubMed |
| 17 | 10328106 | Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. | J Natl Cancer Inst | 1999 | https://conductscience.org/library/papers/10328106 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42766263 | Opportunities in cancer gene therapy: inhibiting MDM2 and restoring p14ARF as a means to activate p53. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42766263 | PubMed |
| 41884820 | The guardian of the genome meets immunotherapy: p53-based strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/41884820 | PubMed |
| 39961936 | Integrating alternative therapies in overcoming chemotherapy resistance in tumors. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39961936 | PubMed |
| 39598704 | Advancements in p53-Based Anti-Tumor Gene Therapy Research. | Molecules | 2024 | https://conductscience.org/library/papers/39598704 | PubMed |
| 34769370 | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward? | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769370 | PubMed |
| 34769259 | Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769259 | PubMed |
| 33060772 | Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models. | Sci Rep | 2020 | https://conductscience.org/library/papers/33060772 | PubMed |
| 33009508 | The changing face of gastric cancer: epidemiologic trends and advances in novel therapies. | Cancer Gene Ther | 2021 | https://conductscience.org/library/papers/33009508 | PubMed |
| 31384232 | The Evolving Landscape of Gene Therapy in Plastic Surgery. | Semin Plast Surg | 2019 | https://conductscience.org/library/papers/31384232 | PubMed |
| 31346579 | Multidisciplinary oncolytic virotherapy for gastrointestinal cancer. | Ann Gastroenterol Surg | 2019 | https://conductscience.org/library/papers/31346579 | PubMed |
| 31015790 | Prostate Cancer Gene Regulatory Network Inferred from RNA-Seq Data. | Curr Genomics | 2019 | https://conductscience.org/library/papers/31015790 | PubMed |
| 30198865 | Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma. | Cancer Biomark | 2018 | https://conductscience.org/library/papers/30198865 | PubMed |
| 30170471 | Recombinant adenovirus-p53 enhances the therapeutic effect of surgery and chemoradiotherapy combination in hypopharyngeal squamous cell carcinomas patients. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30170471 | PubMed |
| 30087719 | TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma. | Open Access Maced J Med Sci | 2018 | https://conductscience.org/library/papers/30087719 | PubMed |
| 30003189 | p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma. | Ann Gastroenterol Surg | 2018 | https://conductscience.org/library/papers/30003189 | PubMed |
| 26900290 | Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26900290 | PubMed |
| 26445307 | Targeting tumor suppressor genes for cancer therapy. | Bioessays | 2015 | https://conductscience.org/library/papers/26445307 | PubMed |
| 26241176 | Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams. | Gene Ther | 2016 | https://conductscience.org/library/papers/26241176 | PubMed |
| 26059686 | Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26059686 | PubMed |
| 25732051 | Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo. | Sci Rep | 2015 | https://conductscience.org/library/papers/25732051 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16734736
GET https://conductscience.org/api/papers/v1/16734736/cited_by?page=2